- Fund Type: Open-End Fund
- Objective: Region Fund-Nordic
- Asset Class: Equity
- Geographic Focus: Nordic Region
Snapshot for Nordea Nordic (MERAVAI)
| Year To Date: | +2.91% | 3-Month: | -2.68% | 3-Year: | +7.18% | 52-Week Range: | 6.97 - 9.03 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -4.83% | 1-Year: | +20.80% | 5-Year: | +1.73% | Beta vs MXEU: | 1.16 |
Fund Profile & Information for MERAVAI
Nordea Nordic Fund is an open-end fund registered in Finland. The Fund invests in Nordic equities regarded to have a large growth potential.
| Inception Date: | 10-15-1987 | Telephone: | 358-9-1651 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.nordea.fi | ||
Fundamentals for MERAVAI
| NAV | (on 2013-06-18) 8.51 |
|---|---|
| Assets (M) | (on 2013-04-30) 212.03 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for MERAVAI
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-02-02) 0.07 |
| Dividend Yield (ttm) | - |
Fees & Expenses for MERAVAI
| Front Load | 1.00 |
|---|---|
| Back Load | 1.00 |
| Current Mgmt Fee | 2.30 |
| Redemption Fee | 1.00 |
| 12b1 Fee | - |
| Expense Ratio | 2.31 |
Top Fund Holdings for MERAVAI
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Novo Nordisk A/S | 90,409 | 11,423,822 | 5.287% |
| Swedbank AB | 613,983 | 10,889,787 | 5.040% |
| Volvo AB | 916,641 | 10,394,254 | 4.810% |
| Metso OYJ | 257,835 | 8,531,760 | 3.948% |
| Danske Bank A/S | 585,401 | 8,087,970 | 3.743% |
| Autoliv Inc | 150,232 | 8,069,193 | 3.734% |
| Schibsted ASA | 222,372 | 7,698,030 | 3.562% |
| Atlas Copco AB | 356,011 | 7,013,068 | 3.245% |
| Hennes & Mauritz AB | 241,787 | 6,742,232 | 3.120% |
| Subsea 7 SA | 356,457 | 6,478,373 | 2.998% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page